H.C. Wainwright Reiterates Buy Rating on Vera Therapeutics (VERA)

November 28, 2025 6:35 AM EST Send to a Friend
H.C. Wainwright analyst Arthur He reiterated a Buy rating and $90.00 price target on Vera Therapeutics (NASDAQ: VERA).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login